Welcome to our dedicated page for Praetorian Acqsn SEC filings (Ticker: PTOR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Praetorian Acqsn's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Praetorian Acqsn's regulatory disclosures and financial reporting.
Praetorian Acquisition Corp. (PTOR) is a Cayman Islands special purpose acquisition company formed on September 29, 2025 to complete a merger or similar business combination, with a focus on traditional sectors that can be transformed by automation and artificial intelligence.
The company completed an IPO on January 26, 2026, selling 22,000,000 units at $10.00 each, followed by a full 3,300,000-unit over-allotment, and deposited a total of $253,000,000 into a Nasdaq-linked trust account. As of March 23, 2026, it had 33,923,083 Class A ordinary shares and 8,433,333 Class B ordinary shares outstanding.
Praetorian must complete an initial business combination by January 26, 2028, or by April 26, 2028 if certain agreements are in place, or otherwise liquidate and return trust funds to public shareholders. The filing highlights significant potential dilution from founder shares and private placement warrants and outlines extensive redemption rights and SPAC-specific regulatory and competitive risks.